TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Carbon monoxide exhaled air
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subject hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Decision-Making Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to Supplement Intake (estimated using unused portion of supplements)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to Supplement Intake (Number of missed doses/week)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of Study visits (Number of studies with completed tasks)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Bone volumetric changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline cancer-specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rigidity at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in angle kappa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intensive care mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change in misophonia symptoms measured by S-Five - Externalizing subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in misophonia symptoms measured by S-Five - Internalizing subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in misophonia symptoms measured by S-Five - Threat subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in misophonia symptoms measured by S-Five - Impact subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in misophonia symptoms measured by S-Five - Outburst subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant Adherence to Plavix as Measured by Clopidogrel Metabolites in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detection of gastric lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Vitamin D plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Z-score and T-score of femur and lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of filter clotting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in Functional Score by Task (WMFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Completion Time by Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight Lifted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of unreadable biopsy slides
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of major structural defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Stigma subscale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of stones cleared
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Degree of Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Limitation of Jaw Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of Impact on Oral-health Related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: rate of covid symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of inflammatory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Timed Up and Go Test (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Romberg Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of physician gestalt in diagnosing COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive likelihood ratio of physician gestalt in diagnosing COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative likelihood ratio of physician gestalt in diagnosing COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in baseline Ees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects achieving successful neutrophil engraftment within 42 days after BRL-103 infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cognitive performance on task switch test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Complications during recovery-extubation
Endpoint domain: Adverse events/effects
Primary endpoint: Cognition assessed using the Hopkins Verbal Learning Test (HVLT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognition assessed using the WAIS-IV Digit Span
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognition assessed using the Oral Trail Making Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognition assessed using the COWA Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: difficulty score for swallowing the capsule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time required to swallow the capsule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate for swallowing the capsule at the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in symptoms experienced
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the ability to perform daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Eradication rate of helicobacter pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Agreement of visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar Range of Motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg Length Discrepancy (LLD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar Lordotic Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Indirect Fick Cardiac Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of postoperative depression
Endpoint domain: Adverse events/effects
Primary endpoint: Application Usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Frequency of Past-month Alcohol Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quantity of Past-month Alcohol Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in buccal/labial vertical bone dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: MMP-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-Year Progressive Free Survival (PFS) Rate
Endpoint domain: Mortality/survival
Primary endpoint: Quantitative assessment of image quality (apparent signal-to-noise and contrast-to-noise ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of agreement on PI-RADS ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Missed clinic appointments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diurnal Difference in Liver Volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with PCI abnormal haematology variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of subjects with PCI abnormal clinical chemistry variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with PCI and/or abnormal electrocardiogram variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of subjects with PCI abnormal vital sign variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants receiving the allocated treatment at 48 weeks
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of participants receiving the allocated treatment at 96 weeks
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence to treatment as assessed by Participant Dosing Diaries
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diagnostic accuracy of CADx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportions of patients discharged within 30 min after bronchoscopy
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mydriatic efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Imaging surveillance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Renal and urinary involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Angiographic percent diameter stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Wear time monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fit monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of glans dehiscence
Endpoint domain: Adverse events/effects
Primary endpoint: frequency of meatal stenosis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with solicited local and systemic Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with all AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with Medically Attended Adverse Events (MAAEs), Adverse Events of Special Interest (AESIs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of individual subject successes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Complete response rate (CR+CRi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV transcription (cell-associated HIV RNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hamilton Anxiety Rating scale (HAM-A)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Fatigue Impact Scale (FIS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Proportion of participants linked to PrEP or ART
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement in reading abilities assessed by CTOPP-2 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in reading abilities assessed by GLAD scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in reading abilities assessed by WRAT-5 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Binocular Visual Acuity (VA) With Study Lenses at 4 Meters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnostic capabilities of magnetocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in participants' satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of children with HBsAg positive
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Ability to remove secretion from tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of HB/LBB capture or significant increase in pacing threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Readiness for Interprofessional Learning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improved participant reported outcome measures (PROMs)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fusion status after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic Clearance Rate of Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Color masking potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of hypophosphatasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference weights or utilities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sTREM-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: sTREM-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presepsin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acute liver injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of 68Ga-FAP-RGD PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in intraventricular ICP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of unsolicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Changes of blood chemistry, blood routine, blood coagulation function and urinalysis indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to ICS therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients with complete clearance of flat warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of allergy medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety of allergy medication
Endpoint domain: Adverse events/effects
Primary endpoint: Tissue Gasdermin D expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: superficial and deep vascular densities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: foveal avascular zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Two-year progression-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Nurses Knowledge and competency regarding dysphagia scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Classification of pancreatic exocrine insufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Revised Fibromyalgia Impact Questionnaire (FIQR) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Absence of conventional hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Affective dimension of dyspnea
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Myokine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual tumor DNA on operating bed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lumbar puncture pressure measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Blood Glucose Level (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in air quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in peri-operative pain location and intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in opioid consumption per 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the opioid side effect of urinary retention
Endpoint domain: Adverse events/effects
Primary endpoint: Left Ventricle Outflow Tract (LVOT) First Ventilatory Threshold VTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neurological function prognosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hypersensitivity during DPT
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in vertigo intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Near Vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of Distance Vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Digit span backwards
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prevalence of Mental Health (MH) issues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient compliance to follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety of STC314 injection
Endpoint domain: Adverse events/effects
Primary endpoint: irritable bowel syndrome Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Index hospital length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change from Baseline in Hemoglobin A1C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in Glucose Levels measured by Continuous Glucose Monitor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline distance walked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the serum concentration-time curve (AUC) of zanamivir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed serum concentration (Cmax) of zanamivir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance (CL) in plasma following administration of zanamivir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal half-life (t1/2) of zanamivir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level at 3 months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Executive Function Challenge Task (EFCT) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Neural Response During Prototype Learning Task Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in pre-procedural device size selection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who fell sick and vomit
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who fell constipate
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who fell difficulty urinating
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who fell lethargy
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who fell dizziness, difficulty breathing, biliary colic, headache, stomachache, or anorexia
Endpoint domain: Adverse events/effects
Primary endpoint: Time to open eyes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PACU discharge time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient reported outcomes
Endpoint domain: Life impact
Primary endpoint: Average time to complete FLS tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants who are re-hospitalized
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Global Costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completion of scheduled visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sensitivity of 68-Gallium -Fibroblast Activating Protein Inhibitor - 46 PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach the most cephalad/cranial sensory block level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to reach sensory block level of L1 or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to reach sensory block level T10 or higher
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes